GSK Slashes Patent Protection In Lower-Income Countries

 
• By Francesca Bruce

GlaxoSmithKline says it will no longer be filing for patent protection for its medicines in leastdeveloped and low-income countries. The firm is also set to be the first company ever to commit future oncology products to patent pooling.

More from Anti-infective

More from Therapy Areas